Home Alternative Medizin Bisse und Stiche Krebs AGB-Behandlungen Zahngesundheit Diät und Ernährung Familiengesundheit Gesundheitsindustrie
|  | Gesundheitswissenschaften >  | Krebs | Krebs-Behandlungen

Cancer Surgery: Curative Intent, Staging, Types, and Multimodal Integration

Surgery remains the primary curative modality for most solid tumors. Its role extends beyond resection to staging, palliation, and enabling multimodal therapy.

Curative Surgery

  • Goal: Complete macroscopic and microscopic resection (R0 resection: negative margins).
  • Applicable to: Localized/regional disease (Stage I–III for many cancers).
  • Cure rates: High for early-stage breast, colon, melanoma, testicular, thyroid, etc.

Surgical Staging and Diagnosis

  • Defines T (tumor size/invasion), N (nodal status), M (metastasis) — TNM staging.
  • Lymphadenectomy (sentinel node biopsy or formal dissection) critical for nodal staging.
  • Tissue for molecular profiling (ER/PR/HER2, KRAS, MSI, PD-L1, NTRK) guiding adjuvant/targeted therapy.

Types of Cancer Surgery

TypeDescriptionExamples
Diagnostic biopsyTissue confirmationCore needle, excisional, endoscopic
Local excisionTumor + narrow marginSmall breast lump, early melanoma, polyp
Wide local excisionTumor + 1–2 cm marginBreast conservation, soft tissue sarcoma
Radical/composite resectionTumor + organ + nodes + adjacent structuresWhipple (pancreas), cystectomy (bladder), esophagectomy
Mohs micrographicLayer-by-layer with frozen section margin controlHigh-risk BCC/SCC (face, hands)
Debulking / CytoreductionReduce tumor burden (not curative alone)Advanced ovarian, peritoneal metastases
PalliativeRelieve obstruction, bleeding, painStenting, bypass, kyphoplasty
ProphylacticRisk reduction in high-risk geneticsMastectomy (BRCA), colectomy (FAP)
ReconstructiveRestore form/function after ablationBreast recon (implant/flap), mandible fibula flap

Multidisciplinary Integration

  • Neoadjuvant therapy: Shrink tumor → enable resection, assess response, treat micromets early (breast, rectal, esophageal, sarcoma).
  • Adjuvant therapy: Post-op chemo/radiation/targeted/immunotherapy based on pathology.
  • Tumor Board: Surgeon, medical/rad onc, path, rads, genetics, nursing — consensus plan.

Perioperative Optimization

  • Prehabilitation: exercise, nutrition, smoking cessation, anemia correction.
  • ERAS (Enhanced Recovery After Surgery) protocols: reduce complications, LOS.
  • Minimally invasive (laparoscopic, robotic) when oncologically equivalent.

Quality Metrics

  • R0 resection rate, lymph node harvest, margin distance, 30-day mortality, 5-year survival.
  • High-volume centers/surgeons → better outcomes for complex resections.

Surgery is not standalone; it is the cornerstone of a multimodal strategy tailored to tumor biology and patient factors.

logo

www.alskrankheit.net © Gesundheitswissenschaften